Globally, Versius is the second most utilized surgical robotic system, withover26,000 surgical procedures completed across Europe, Latin America, Asia, Middle East and Africa With its unique compact ...

Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform, Versius ...

After a record quarter, CMR closes the year with a Versius global install base more than 50% higher than 2022 Over 17,000 surgical procedures completed using Versius, representing a procedural growth ...

CMR Surgical won Food and Drug Administration authorization for its Versius robot with an initial indication for gallbladder removal surgery. CMR will partner with select hospitals as the first part ...

CMR Surgical launches vLimeLite * a new imaging technology to visualise ICG, the first product launch in a series of 2024 product releases as part of Versius Plus, a significant enhancement to the ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

The U.S. FDA recently cleared Medtronic plc’s Hugo robotic-assisted surgery system and CMR Surgical Ltd.’s Versius Plus system, adding new options to the U.S. market to meet rising demand for robotic ...

Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing competition for longtime industry leader Intuitive Surgical.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.